Variables | Adrenal cortical hormones | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | Model 4 | |||||||||||||||||
β | SE | t | df | P-Value | β | SE | t | df | P-Value | β | SE | t | df | P-Value | β | SE | t | df | P-Value | |
Intercept | 0.30 | 0.01 | 32.20 | 246 | <.0001 | 0.38 | 0.09 | 4.38 | 246 | <.0001 | 0.31 | 0.03 | 9.15 | 241 | <.0001 | 0.41 | 0.09 | 4.48 | 241 | <.0001 |
Pharmacists and pharmacy characteristics | ||||||||||||||||||||
Sex of pharmacist | ||||||||||||||||||||
Male | 0.00 | 0.01 | −0.02 | 243 | 0.9876 | 0.00 | 0.01 | −0.19 | 243 | 0.8498 | ||||||||||
Female | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Age of pharmacist (years) | ||||||||||||||||||||
≤45 | 0.04 | 0.02 | 2.25 | 722 | 0.0251 | 0.03 | 0.02 | 2.10 | 722 | 0.0361 | ||||||||||
46–55 | 0.00 | 0.02 | −0.21 | 722 | 0.8342 | −0.01 | 0.02 | −0.37 | 722 | 0.7139 | ||||||||||
56–65 | −0.02 | 0.02 | −0.93 | 722 | 0.3528 | −0.02 | 0.02 | −1.01 | 722 | 0.3152 | ||||||||||
≥66 | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Length of operation | ||||||||||||||||||||
≤12 months | 0.05 | 0.02 | 2.78 | 454 | 0.0057 | 0.05 | 0.02 | 2.74 | 454 | 0.0064 | ||||||||||
13–24 months | 0.03 | 0.02 | 1.92 | 454 | 0.0555 | 0.03 | 0.02 | 1.89 | 454 | 0.0595 | ||||||||||
≥25 months | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Separation of drug prescribing and dispensing | ||||||||||||||||||||
Exception | 0.72 | 0.07 | 10.05 | 93 | <.0001 | 0.72 | 0.07 | 9.92 | 93 | <.0001 | ||||||||||
Application | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Period of exclusion for reformed program | ||||||||||||||||||||
≤18 months | −0.10 | 0.09 | −1.16 | 88 | 0.2484 | −0.10 | 0.09 | −1.17 | 88 | 0.2442 | ||||||||||
≥19 months | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Total drug purchase (10 million KRW) | 0.00 | 0.00 | −3.68 | 16,000 | 0.0002 | 0.00 | 0.00 | −3.68 | 16,000 | 0.0002 | ||||||||||
Regional characteristics | ||||||||||||||||||||
Region | ||||||||||||||||||||
Metropolitan | −0.06 | 0.02 | −3.00 | 241 | 0.0030 | −0.04 | 0.02 | −2.07 | 241 | 0.0395 | ||||||||||
Non-metropolitan | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Total number of clinics in regions with pharmacies | ||||||||||||||||||||
≤60 | 0.01 | 0.03 | 0.24 | 241 | 0.8108 | −0.01 | 0.02 | −0.27 | 241 | 0.7887 | ||||||||||
≥61 | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Total number of pharmacy in regions with pharmacies | ||||||||||||||||||||
≤45 | 0.02 | 0.02 | 0.98 | 241 | 0.3303 | 0.01 | 0.02 | 0.50 | 241 | 0.6149 | ||||||||||
≥46 | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Average of individual income in regions with pharmacies | ||||||||||||||||||||
≤38 million KRW | 0.01 | 0.02 | 0.37 | 241 | 0.7088 | −0.01 | 0.02 | −0.31 | 241 | 0.7555 | ||||||||||
≥39 million KRW | Ref | - | - | Ref | - | - | Ref | - | - | Ref | - | - | ||||||||
Proportion of national basic livelihood security beneficiaries in regions with pharmacies | 0.00 | 0.01 | −0.72 | 241 | 0.4740 | 0.00 | 0.01 | −0.52 | 241 | 0.6035 | ||||||||||
Random parta | Variance | SE | Z | P-Value | Variance | SE | Z | P-Value | Variance | SE | Z | P-Value | Variance | SD | Z | P-Value | ||||
Variance of the intercept at the regional level | 0.01 | 0.00 | 4.76 | <.0001 | 0.01 | 0.00 | 4.13 | <.0001 | 0.01 | 0.00 | 4.42 | <.0001 | 0.01 | 0.00 | 3.99 | <.0001 | ||||
Variance of the intercept at the pharmacy level | 0.48 | 0.01 | 89.74 | <.0001 | 0.47 | 0.01 | 89.77 | <.0001 | 0.48 | 0.01 | 89.72 | <.0001 | 0.47 | 0.01 | 89.76 | <.0001 | ||||
ICC | 0.0223 | 0.0151 | 0.0199 | 0.0149 |